|
|
|
This is the preliminary program for the 2007 Joint Statistical
Meetings in Salt Lake City, Utah.
|
|
|
The views expressed here are those of the individual authors and not necessarily those of the ASA or its board, officers, or staff. Back to main JSM 2007 Program page |
= Applied Session,
= Theme Session,
= Presenter
11
|
Sun, 7/29/07, 2:00 PM - 3:50 PM | CC-155 B |
| Alzheimer's Disease Research in Utah: Analysis Methods for Early Detection, Epidemiology and Clinical Trials - Invited - Papers | ||
|
ASA, Utah Chapter, Council of Chapters, ENAR, Section on Statistics in Epidemiology, Biometrics Section |
||
| Organizer(s): Suzanne Hendrix, Myriad Pharmaceuticals | ||
| Chair(s): C. Shane Reese, Brigham Young University | ||
| 2:05 PM |
Cognitive Change as a Biomarker in the Early Detection of Alzheimer's Disease —  Gordon J. Chelune, The University of Utah
|
|
| 2:35 PM |
Analyzing Repeated Neuropsychiatric, Cognitive, and Functional Measures in a Population-Based Study of Dementia — Chris Corcoran, Utah State University; Carl F. Pieper, Duke University; Peter Zandi, Johns Hopkins University
|
|
| 3:05 PM |
Responder versus Means Analysis: Illustrated with Data from a Phase 2 Study of Tarenflurbil (MPC-7869) in Alzheimer's Disease (AD) — Kenton Zavitz, Myriad Pharmaceuticals; Mark Laughlin, Myriad Pharmaceuticals; Edward Swabb, Myriad Pharmaceuticals
|
|
| 3:35 PM | Floor Discussion | |
|
JSM 2007
For information, contact jsm@amstat.org
or phone (888) 231-3473. If you have questions about the Continuing Education program,
please contact the Education Department. |